DrugDashboards

Market view

carbamazepine · Suspension

9 marketed package NDCs · 6 active manufacturers

Most dispensed: 400 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 200 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 100 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 200 mg · Tablet · #100 tablets/bottle

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 14% over the past year, to $0.0960 per mL. The brand runs $0.4370 per mL 4.6× more.

Price range and competition

RSS: changes for this drug
priced separately — they are not the same market

Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.05$0.1$0.15Jan 2023Sep 202606companies actively selling

Latest · Sep 2026 — typical price $0.096 · middle half $0.096$0.096 · full range $0.096$0.096 · 3 products · 6 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per mLSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for carbamazepine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • CarbamazepineAug 28, 2026
    Mfr entered
    American Health Packaging · carbamazepine
  • CarbamazepineAug 28, 2026
    New product
    American Health Packaging
  • CarbamazepineAug 19, 2026
    Price up
    NADAC $0.11701 → $0.11904 per unit (+1.73%)
  • CarbamazepineAug 19, 2026
    Price up
    NADAC $0.11701 → $0.11904 per unit (+1.73%)
  • CarbamazepineAug 19, 2026
    Price up
    NADAC $0.09547 → $0.09596 per unit (+0.51%)
  • CarbamazepineAug 19, 2026
    Price up
    NADAC $0.11701 → $0.11904 per unit (+1.73%)
  • CarbamazepineAug 19, 2026
    Price up
    NADAC $0.11701 → $0.11904 per unit (+1.73%)
  • carbamazepineAug 19, 2026
    Price down
    NADAC $0.61752 → $0.61327 per unit (-0.69%)
  • carbamazepineAug 19, 2026
    Price up
    NADAC $0.36858 → $0.37763 per unit (+2.46%)
  • carbamazepineAug 19, 2026
    Price down
    NADAC $0.21341 → $0.19893 per unit (-6.79%)

Same drug class

Other molecules FDA puts in Mood Stabilizer, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Carbamazepine in shortage right now?
No. FDA does not currently list Carbamazepine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Carbamazepine?
59 companies have marketed Carbamazepine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Carbamazepine cost?
The typical pharmacy pays about $0.3776 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.